Elevance Health, Inc. 2025 Annual Report (10-K) Summary
Business Context and Reporting Period
This summary covers the Annual Report on Form 10-K for Elevance Health, Inc. for the fiscal year ended December 31, 2025. Elevance is one of the largest health insurers in the United States, serving approximately 45.2 million medical members as of year-end. The company operates through four reportable segments: Health Benefits, CarelonRx (pharmacy services), Carelon Services (healthcare services), and Corporate & Other. It is an independent licensee of the Blue Cross and Blue Shield Association (BCBSA) and operates under brands including Anthem Blue Cross, Wellpoint, and Carelon.
Key Financial Metrics
| Metric | 2025 | 2024 | Change |
|---|---|---|---|
| Total Operating Revenue | $197,584 million | $175,204 million | +12.8% |
| Shareholders' Net Income | $5,662 million | $5,980 million | -5.3% |
| Diluted EPS | $25.21 | $25.68 | -1.8% |
| Operating Cash Flow | $4,290 million | $5,808 million | -26.1% |
| Total Assets | $121,494 million | $116,889 million | +3.9% |
| Total Debt | $31,896 million | $30,867 million | +3.3% |
| Debt-to-Capital Ratio | 42.1% | 43.0% | -0.9 pp |
| Benefit Expense Ratio | 90.0% | 88.5% | +150 bps |
| Operating Expense Ratio | 10.6% | 11.4% | -80 bps |
Material Changes vs. Prior Period
- Revenue Growth: Operating revenue increased by $22.4 billion (12.8%), driven primarily by premium rate increases in the Health Benefits segment to offset medical cost trends, growth in Medicare Advantage membership, and recent acquisitions. This was partially offset by Medicaid membership attrition due to eligibility redeterminations.
- Profitability Decline: Net income decreased by $318 million (5.3%) and operating gain in the Health Benefits segment fell by 33.4% ($2.1 billion). The decline was primarily due to elevated medical cost trends across all lines of business, particularly in the ACA Individual market, and increased investments in workforce and technology.
- Cash Flow Impact: Operating cash flow decreased significantly, largely due to a $666 million payment made in September 2025 related to the BCBSA Provider Settlement Agreement, unfavorable working capital impacts, and lower net income.
- Membership Trends: Total medical membership decreased by 0.5 million (1.1%). Medicaid membership declined by 4.7% due to redeterminations, while Medicare Advantage membership grew by 7.9%.
- Acquisitions: The company completed the acquisition of CareBridge (December 2024) and Centers Plan for Healthy Living (December 2024), contributing to revenue growth in Carelon Services and Health Benefits.
Guidance, Outlook, and Risks
Management Commentary: Management highlighted the expiration of enhanced Premium Tax Credits (PTCs) on December 31, 2025, which may lead to increased premiums and potential enrollment declines in the Individual market. The company continues to focus on managing medical cost trends through value-based care and provider contracting. The 2026 CMS Star Ratings were released in October 2025, with approximately 59% of Medicare Advantage members in plans rated 4.0 stars or higher, up from 40% in the prior year.
Regulatory Environment: The company faces significant regulatory uncertainty, including the "One Big Beautiful Bill Act" (OBBBA) signed in July 2025, which introduces work requirements and cost-sharing for Medicaid expansion populations. Additionally, new pharmacy benefit manager (PBM) reforms passed in February 2026 will require rebate pass-throughs and delink PBM compensation in Medicare Part D by 2028.
Key Risks:
- Medical Cost Trends: Rising healthcare costs and utilization rates, particularly in the Individual and Medicaid markets, pose a risk to profitability if not offset by premium increases.
- Regulatory Changes: Changes to Medicaid eligibility, Medicare Advantage payment methodologies, and PBM regulations could materially impact revenue and margins.
- BCBSA Litigation: While the Provider Settlement Agreement was finalized in August 2025, follow-on cases from entities that opted out remain pending.
- Cybersecurity: The company faces ongoing risks from cyber-attacks and data privacy incidents, which could disrupt operations and incur significant costs.
Investor Verification Checklist
- Medical Cost Trend Accuracy: Verify the company's ability to predict and manage medical cost trends, especially in the Individual ACA market where morbidity has increased following the expiration of enhanced subsidies.
- Medicaid Redetermination Impact: Assess the long-term impact of Medicaid eligibility redeterminations on membership levels and revenue stability.
- BCBSA Settlement Follow-ons: Monitor the status of follow-on litigation cases from entities that opted out of the BCBSA Provider Settlement Agreement.
- PBM Reform Implications: Evaluate the potential financial impact of the new federal PBM reforms requiring rebate pass-throughs and compensation delinking, effective 2028 for Medicare Part D.
- Star Ratings Performance: Confirm the sustainability of the improved 2026 CMS Star Ratings and the associated bonus payments for 2027.
- Debt Covenants: Review compliance with debt covenants, specifically the 60% debt-to-capital ratio limit under the 5-Year Facility, given the current ratio of 42.1%.